Från innovation till patient: Vilka reformer krävs för att medicinsk innovation ska nå patienterna?

On Wednesday 24 June, we organise Life Science-dagen in a large tent at Hamnplan, in collaboration with AbbVie, AstraZeneca, Chiesi, Lund University, Novo Nordisk, Roche and SmiLe Venture Hub.

At 14.00-14.45, there will be a seminar in Swedish on ”Från innovation till patient: Vilka reformer krävs för att medicinsk innovation ska nå patienterna?”, hosted by Roche. Please note that the program and its speakers/panelists might be updated before it takes place – updated program in the official program for Almedalsveckan.

Seminar focus

Unequal access to innovative treatments is affecting Swedish patients. To create better conditions, Sweden needs to ensure sustainable funding for the implementation of new treatments. Joint political action is now required – but which reforms are possible at national and regional level?

Medical breakthroughs create hope, but in Sweden the path to the patient is becoming increasingly long. To maintain our position as a leading life science nation, a shift is needed where we look beyond the short-term price tag.

New treatments should be regarded as an investment in society, where the cost is weighed against a healthier population, increased productivity, and reduced pressure on healthcare and social care services. When access to innovation is delayed, not only patients’ wellbeing is at risk, but also Sweden’s attractiveness for cutting-edge research. To secure the future, reforms are needed that prioritise the implementation of innovation in healthcare and ensure sustainable funding.

Could greater government responsibility reduce geographical disparities and accelerate access to new treatments? How do we create room for investments with long-term value, and how can we safeguard Sweden’s international competitiveness?

Speakers:

• Amir Abass, Member and Board Member, Ung Cancer
• Charlie Grafström, Director of Public Affairs and Pricing & Reimbursement, Roche AB
• Christian Carlsson (KD), Chair of the Committee on Health and Welfare, Swedish Parliament, Christian Democrats
• Helena Proos (S), Chair of the Regional Executive Board, Region Uppsala, Social Democrats
• Martin Engström, Director of Health and Medical Services, Region Skåne
• Niklas Hedberg, Chief Pharmacist, TLV
• Tina Mansson Söderlund, Head of Section for Healthcare Services, SKR
• Petter Hartman, CEO (moderator), Medicon Village Innovation

Life Science-dagen aims to establish a high-profile, unified forum and meeting point dedicated to life science at Almedalsveckan, in line with our role as the largest life science park in Scandinavia.

During Almedalsveckan 2026 Medicon Village also organise Skånes Innovationsarena on Thursday 25 June.

For more information on Life Science-dagen, please contact mikael.lagerwall@mediconvillage.se.